1st Quarter - Report
HOOPER, LUNDY & BOOKMAN, P.C. for ROCHE DIAGNOSTICS CORPORATION
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R. 1892 - The Bipartisan Budget Act of 2018
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | — |
Medicare/Medicaid MMM
H.R. 3271 and S.1914 - Protecting Access to Diabetic Testing Supplies Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
Health Issues HCR
Discussion Draft for a regulatory framework for in-vitro clinical tests (Diagnostic Accuracy & Innovation Act or DAIA); Pandemic All-Hazards Preparedness Reauthorization Act; H.R. 3271 and S.1914 - Protecting Access to Diabetic Testing Supplies Act of 2017 .
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA LAYMAN | SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.